FeesSafety
Pluang+

Bitcoin's rise above $80K signals end of bear market, says Kraken co-CEO

Market News
10 Nov 2026, 14:33 WIB
Tokenpost
View Source
Bullish
Bitcoin's rise above $80K signals end of bear market, says Kraken co-CEO

Kraken co-CEO Dave Ripley stated that Bitcoin's recent surge past $80,000 suggests the bear market is mostly over, marking a shift from previous views that the downturn was ongoing. He described this bear market as potentially the softest in Bitcoin's history and expressed optimism about the market's recovery. This perspective contrasts with a recent bear market count that dated the downturn's start to October 2025 and estimated a 53% decline. Ripley's comments highlight growing confidence among both retail and institutional investors in Bitcoin's future.

Bitcoin's recent surge past $80,000 is notable context for Kraken Co-CEO Dave Ripley's comments on the bear market. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 10, 2026 19:44 WIB: out of 50 priced major cryptocurrencies, 30 rose and 19 fell today. Notable movers include BAL (Balancer) at Rp16.297 with a 1-day change of +11.14%, ZIL (Zilliqa) at Rp30 with a 1-day change of -10.73% and a Pluang order activity of 39% Sell / 61% Buy, and EOS (EOS.IO) at Rp12.649 with a 1-day change of +8.13%.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
52 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
52 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
52 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
52 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App